D.E. Shaw & Co’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,181
| Closed | -$145K | – | 4506 |
|
|
2022
Q1 | $145K | Buy |
+12,181
| New | +$145K | ﹤0.01% | 3698 |
|
|
2021
Q2 | – | Sell |
-3,768
| Closed | -$282K | – | 3813 |
|
|
2021
Q1 | $282K | Sell |
3,768
-19,601
| -84% | -$1.47M | ﹤0.01% | 2686 |
|
|
2020
Q4 | $2.54M | Buy |
23,369
+4,251
| +22% | +$461K | ﹤0.01% | 1636 |
|
|
2020
Q3 | $1.69M | Sell |
19,118
-4,125
| -18% | -$365K | ﹤0.01% | 1692 |
|
|
2020
Q2 | $2.48M | Buy |
23,243
+14,761
| +174% | +$1.57M | ﹤0.01% | 1498 |
|
|
2020
Q1 | $503K | Sell |
8,482
-6,226
| -42% | -$369K | ﹤0.01% | 2142 |
|
|
2019
Q4 | $1.02M | Buy |
14,708
+7,414
| +102% | +$513K | ﹤0.01% | 1911 |
|
|
2019
Q3 | $757K | Sell |
7,294
-2,139
| -23% | -$222K | ﹤0.01% | 1946 |
|
|
2019
Q2 | $873K | Sell |
9,433
-1,836
| -16% | -$170K | ﹤0.01% | 1932 |
|
|
2019
Q1 | $1.03M | Buy |
11,269
+2,381
| +27% | +$218K | ﹤0.01% | 1842 |
|
|
2018
Q4 | $496K | Buy |
8,888
+7,859
| +764% | +$439K | ﹤0.01% | 2103 |
|
|
2018
Q3 | $123K | Buy |
+1,029
| New | +$123K | ﹤0.01% | 2423 |
|